A multicenter clinical study to determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood stem-cell transplantation

Maintenance therapy with lenalidomide (LEN) for patients with multiple myeloma (MM) following autologous peripheral blood stem cell transplantation (auto-PBSCT) may be a promising option for preventing relapse or disease progression. However, the recommended dose of LEN has yet to be firmly establis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: YAMAMOTO, MASAHIDE, OHASHI, KAZUTERU, KAKIHANA, KAZUHIKO, NAKAMURA, YUICHI, KOMENO, TAKUYA, KOJIMA, HIROSHI, MORITA, SATOSHI, SAKAMAKI, HISASHI
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888028/
https://ncbi.nlm.nih.gov/pubmed/27313858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.833
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars